Canada Pension Plan Investment Board’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195K Sell
17,900
-69,000
-79% -$862K ﹤0.01% 1574
2025
Q4
$1.12M Buy
86,900
+60,100
+224% +$772K ﹤0.01% 1041
2025
Q3
$346K Sell
26,800
-7,000
-21% -$93.5K ﹤0.01% 1068
2025
Q2
$602K Buy
33,800
+27,200
+412% +$474K ﹤0.01% 1013
2025
Q1
$118K Sell
6,600
-1,400
-18% -$31.8K ﹤0.01% 1113
2024
Q4
$238K Sell
8,000
-5,400
-40% -$114K ﹤0.01% 1168
2024
Q3
$209K Sell
13,400
-4,000
-23% -$72.5K ﹤0.01% 1094
2024
Q2
$298K Buy
17,400
+12,400
+248% +$218K ﹤0.01% 1086
2024
Q1
$78.2K Hold
5,000
﹤0.01% 1142
2023
Q4
$74.7K Buy
5,000
+400
+9% +$5.35K ﹤0.01% 1049
2023
Q3
$74.3K Buy
+4,600
New +$133K ﹤0.01% 963
2023
Q2
Sell
-19,000
Closed -$1.14M 1070
2023
Q1
$1.14M Buy
19,000
+17,777
+1,454% +$1.42M ﹤0.01% 875
2022
Q4
$89.7K Buy
1,223
+400
+49% +$30.1K ﹤0.01% 1034
2022
Q3
$63K Sell
823
-900
-52% -$70.2K ﹤0.01% 1108
2022
Q2
$120K Buy
+1,723
New +$130K ﹤0.01% 1122
2021
Q2
Sell
-15,520
Closed -$2.05M 1294
2021
Q1
$2.05M Buy
+15,520
New +$2.46M ﹤0.01% 859
2020
Q3
Sell
-135,700
Closed -$8.05M 1267
2020
Q2
$8.05M Buy
+135,700
New +$8.92M 0.02% 420
2018
Q4
Sell
-130,000
Closed -$6.81M 1322
2018
Q3
$6.81M Buy
+130,000
New +$5.17M 0.01% 738

Other funds holding NVCR

Canada Pension Plan Investment Board's NVCR Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its NovoCure (NVCR) stake by 79% in Q1 2026, selling an estimated $862K and leaving 17,900 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Canada Pension Plan Investment Board first reported a position in NVCR in Q3 2018 and has held it in 18 quarters since. The position peaked at $8.05M in Q2 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Canada Pension Plan Investment Board held 17,900 shares of NovoCure worth $195K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 69,000 NovoCure shares in Q1 2026, an estimated $862K.
  • NovoCure made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1574 holding.
  • Canada Pension Plan Investment Board first reported a position in NovoCure in Q3 2018 and has held it in 18 quarters since.
  • Canada Pension Plan Investment Board's NovoCure position peaked at $8.05M in Q2 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.